1.
Beta-blocker with intrinsic sympathomimetic activity (ISA) and is less likely to cause bradycardia is
2.
Drug combined with valsartan as fixed dose for heart failure management is
3.
Antihypertensive medication commonly associated with persistent dry cough is
4.
Drug responsible for improving survival in heart failure patients by preventing cardiac remodeling is
5.
Site of action of loop diuretics in the nephron is
6.
Antiarrhythmic agent preferred in the treatment of atrial flutter and atrial fibrillation for rate control is
7.
Drug not combined with ACE inhibitors due to the potential risk of causing hyperkalemia is
8.
Drug commonly used to manage ventricular arrhythmias by blocking sodium channels is
9.
First-line drug used to manage vasospastic angina is
10.
Class of antihypertensive drugs particularly beneficial for patients with chronic kidney disease is
11.
Class of drugs recommended as the first-line treatment for hypertension in patients with diabetes is
12.
Drug contraindicated in patients with asthma due to the risk of bronchoconstriction is
13.
Drug not recommended for management of chronic hypertension in pregnancy is
14.
Angiotensin receptor blockers differ from ACE inhibitors by
15.
Drug recommended for the management of heart failure patients with a heart rate >70 beats/minute despite beta-blocker therapy is
16.
Antiarrhythmic drug with very long half-life and has the potential to cause thyroid dysfunction is
17.
Centrally acting antihypertensive agent among the following is
18.
Concurrent use of phosphodiesterase-5 (PDE-5) inhibitors is a contraindication to administer the following drugs _____
19.
Drug most suitable for treating hypertension in patients with benign prostatic hyperplasia is
20.
Drug used to manage hypertensive emergencies due to its rapid onset of action is